Fatigue, treatment satisfaction and health-related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate-resistant prostate cancer-Reference-Cited by-同舟云学术

Fatigue, treatment satisfaction and health-related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate-resistant prostate cancer

Published:2018-11-08 Issue:1 Volume:28 Page:e12949
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Dearden Lindsay¹,Shalet Natalie¹,Artenie Cristiana²,Mills Andrew²,Jackson Claire²,Grant Laura³^ORCID,Gater Adam³

Affiliation:

1. Janssen EMEA HEMAR; High Wycombe UK

2. Adelphi Research UK; Bollington UK

3. Adelphi Values; Bollington UK

Funder

Janssen Pharmaceuticals

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12949/fullpdf

Reference26 articles.

1. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence;Barbosa;Patient Prefer Adherence,2012

2. Enzalutamide in metastatic prostate cancer before chemotherapy;Beer;New England Journal of Medicine,2014

3. Patient statement of satisfaction with antiemetic treatment is related to quality of life;Bosnjak;American Journal of Clinical Oncology,2000

4. Using thematic analysis in psychology;Braun;Qualitative Research in Psychology,2006

5. Increased survival with enzalutamide in prostate cancer after chemotherapy;Cabot;New England Journal of Medicine,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatigue in Prostate Cancer: A Roundtable Discussion and Thematic Literature Review;European Urology Open Science;2024-05

2. A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer;European Urology Oncology;2024-03

3. Real-world outcomes for first line next-generation hormonal agents in metastatic prostate cancer: a systematic review;Future Oncology;2023-11

4. Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews;Frontiers in Oncology;2023-09-27

5. Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment;European Urology Open Science;2023-05